Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Blood Cancer Journal – Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Blood Cancer Journal – Once-weekly versus twice-weekly bortezomib in newly diagnosed multiple myeloma: a real-world analysis
Nature Communications – Genomic surveillance of Plasmodium falciparum could improve monitoring of drug resistance, but implementation has been hampered due to the large and complex…
View this file, and add comments too.
View this file, and add comments too.
Why is it so hard to innovate in the NHS and social care? Pritesh Mistry, Toby Lindsay and Mark Patterson explore the learnings from a…
The government was determined to make this a good news day. It’s just a shame reality isn’t more obliging
Los pacientes en estudios de fase 3 o aquellos patrocinados por grandes compañías farmacéuticas parecen tener un mayor beneficio clínico
Want to know just how valuable it is having your own GP who knows you, and who you see at every appointment? Yesterday the Mail…
A new study has calculated how long you should be sleeping, standing and moving each day for optimal health. And you might be doing more…
Judge says youth could have died as he raises concerns over children accessing treatment from offshore and online unregulated providers
To protect our local river we had to prove it was being used for swimming. But that, bizarrely, is the reason we were rejected, says…